Literature DB >> 21861759

A model of early human embryonic stem cell differentiation reveals inter- and intracellular changes on transition to squamous epithelium.

Vasiliy Galat1, Sergey Malchenko, Yekaterina Galat, Alex Ishkin, Yuri Nikolsky, Steven T Kosak, Bento Marcelo Soares, Philip Iannaccone, John D Crispino, Mary J C Hendrix.   

Abstract

The molecular events leading to human embryonic stem cell (hESC) differentiation are the subject of considerable scrutiny. Here, we characterize an in vitro model that permits analysis of the earliest steps in the transition of hESC colonies to squamous epithelium on basic fibroblast growth factor withdrawal. A set of markers (GSC, CK18, Gata4, Eomes, and Sox17) point to a mesendodermal nature of the epithelial cells with subsequent commitment to definitive endoderm (Sox17, Cdx2, nestin, and Islet1). We assayed alterations in the transcriptome in parallel with the distribution of immunohistochemical markers. Our results indicate that the alterations of tight junctions in pluripotent culture precede the beginning of differentiation. We defined this cell population as "specified," as it is committed toward differentiation. The transitional zone between "specified" pluripotent and differentiated cells displays significant up-regulation of keratin-18 (CK18) along with a decrease in the functional activity of gap junctions and the down-regulation of 2 gap junction proteins, connexin 43 (Cx43) and connexin 45 (Cx45), which is coincidental with substantial elevation of intracellular Ca2+ levels. These findings reveal a set of cellular changes that may represent the earliest markers of in vitro hESC transition to an epithelial phenotype, before the induction of gene expression networks that guide hESC differentiation. Moreover, we hypothesize that these events may be common during the primary steps of hESC commitment to functionally varied epithelial tissue derivatives of different embryological origins.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21861759      PMCID: PMC3353739          DOI: 10.1089/scd.2010.0578

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  59 in total

1.  Presence of functional gap junctions in human embryonic stem cells.

Authors:  Raymond C B Wong; Alice Pébay; Linh T V Nguyen; Karen L L Koh; Martin F Pera
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

2.  Efficient differentiation of human embryonic stem cells to definitive endoderm.

Authors:  Kevin A D'Amour; Alan D Agulnick; Susan Eliazer; Olivia G Kelly; Evert Kroon; Emmanuel E Baetge
Journal:  Nat Biotechnol       Date:  2005-10-28       Impact factor: 54.908

3.  Assessing self-renewal and differentiation in human embryonic stem cell lines.

Authors:  Jingli Cai; Jia Chen; Ying Liu; Takumi Miura; Yongquan Luo; Jeanne F Loring; William J Freed; Mahendra S Rao; Xianmin Zeng
Journal:  Stem Cells       Date:  2005-11-17       Impact factor: 6.277

4.  Epithelial-mesenchymal transition process in human embryonic stem cells cultured in feeder-free conditions.

Authors:  U Ullmann; P In't Veld; C Gilles; K Sermon; M De Rycke; H Van de Velde; A Van Steirteghem; I Liebaers
Journal:  Mol Hum Reprod       Date:  2006-11-07       Impact factor: 4.025

5.  Stem cells and early lineage development.

Authors:  Janet Rossant
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

6.  Restricted ethnic diversity in human embryonic stem cell lines.

Authors:  Louise C Laurent; Caroline M Nievergelt; Candace Lynch; Eyitayo Fakunle; Julie V Harness; Uli Schmidt; Vasiliy Galat; Andrew L Laslett; Timo Otonkoski; Hans S Keirstead; Andrew Schork; Hyun-Sook Park; Jeanne F Loring
Journal:  Nat Methods       Date:  2010-01       Impact factor: 28.547

Review 7.  Protein networks in disease.

Authors:  Trey Ideker; Roded Sharan
Journal:  Genome Res       Date:  2008-04       Impact factor: 9.043

8.  Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers.

Authors:  Rebecca J Leary; Jimmy C Lin; Jordan Cummins; Simina Boca; Laura D Wood; D Williams Parsons; Siân Jones; Tobias Sjöblom; Ben-Ho Park; Ramon Parsons; Joseph Willis; Dawn Dawson; James K V Willson; Tatiana Nikolskaya; Yuri Nikolsky; Levy Kopelovich; Nick Papadopoulos; Len A Pennacchio; Tian-Li Wang; Sanford D Markowitz; Giovanni Parmigiani; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-13       Impact factor: 11.205

9.  Functional analysis of multiple genomic signatures demonstrates that classification algorithms choose phenotype-related genes.

Authors:  W Shi; M Bessarabova; D Dosymbekov; Z Dezso; T Nikolskaya; M Dudoladova; T Serebryiskaya; A Bugrim; A Guryanov; R J Brennan; R Shah; J Dopazo; M Chen; Y Deng; T Shi; G Jurman; C Furlanello; R S Thomas; J C Corton; W Tong; L Shi; Y Nikolsky
Journal:  Pharmacogenomics J       Date:  2010-08       Impact factor: 3.550

10.  Identifying disease-specific genes based on their topological significance in protein networks.

Authors:  Zoltán Dezso; Yuri Nikolsky; Tatiana Nikolskaya; Jeremy Miller; David Cherba; Craig Webb; Andrej Bugrim
Journal:  BMC Syst Biol       Date:  2009-03-23
View more
  9 in total

Review 1.  The utility of stem cells in pediatric urinary bladder regeneration.

Authors:  Philip M Iannaccone; Vasil Galat; Matthew I Bury; Yongchao C Ma; Arun K Sharma
Journal:  Pediatr Res       Date:  2017-11-08       Impact factor: 3.756

2.  C-kit(+) cells isolated from developing kidneys are a novel population of stem cells with regenerative potential.

Authors:  Erika B Rangel; Samirah A Gomes; Raul A Dulce; Courtney Premer; Claudia O Rodrigues; Rosemeire M Kanashiro-Takeuchi; Behzad Oskouei; Decio A Carvalho; Phillip Ruiz; Jochen Reiser; Joshua M Hare
Journal:  Stem Cells       Date:  2013-08       Impact factor: 6.277

3.  Primary Bovine Extra-Embryonic Cultured Cells: A New Resource for the Study of In Vivo Peri-Implanting Phenotypes and Mesoderm Formation.

Authors:  Isabelle Hue; Danièle Evain-Brion; Thierry Fournier; Séverine A Degrelle
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

4.  Cytokine-free directed differentiation of human pluripotent stem cells efficiently produces hemogenic endothelium with lymphoid potential.

Authors:  Yekaterina Galat; Svetlana Dambaeva; Irina Elcheva; Aaruni Khanolkar; Kenneth Beaman; Philip M Iannaccone; Vasiliy Galat
Journal:  Stem Cell Res Ther       Date:  2017-03-17       Impact factor: 6.832

5.  Connexin 43 Functions as a Positive Regulator of Stem Cell Differentiation into Definitive Endoderm and Pancreatic Progenitors.

Authors:  Wendy Yang; Paul D Lampe; Patricia Kensel-Hammes; Jennifer Hesson; Carol B Ware; Laura Crisa; Vincenzo Cirulli
Journal:  iScience       Date:  2019-07-24

6.  hESC expansion and stemness are independent of connexin forty-three-mediated intercellular communication between hESCs and hASC feeder cells.

Authors:  Jin-Su Kim; Daekee Kwon; Seung-Taeh Hwang; Dong Ryul Lee; Sung Han Shim; Hee-Chun Kim; Hansoo Park; Won Kim; Myung-Kwan Han; Soo-Hong Lee
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

7.  Transgene Reactivation in Induced Pluripotent Stem Cell Derivatives and Reversion to Pluripotency of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells.

Authors:  Vasiliy Galat; Yekaterina Galat; Mariana Perepitchka; Lawrence J Jennings; Philip M Iannaccone; Mary J C Hendrix
Journal:  Stem Cells Dev       Date:  2016-06-27       Impact factor: 3.272

8.  Down syndrome iPSC model: endothelial perspective on tumor development.

Authors:  Mariana Perepitchka; Yekaterina Galat; Igor P Beletsky; Philip M Iannaccone; Vasiliy Galat
Journal:  Oncotarget       Date:  2020-09-08

9.  iPSC-derived progenitor stromal cells provide new insights into aberrant musculoskeletal development and resistance to cancer in down syndrome.

Authors:  Yekaterina Galat; Mariana Perepitchka; Irina Elcheva; Stephen Iannaccone; Philip M Iannaccone; Vasiliy Galat
Journal:  Sci Rep       Date:  2020-08-06       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.